![Miao Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Miao Liu
Fondateur chez MingMed Biotechnology Co., Ltd.
Postes actifs de Miao Liu
Sociétés | Poste | Début | Fin |
---|---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Directeur/Membre du Conseil | 10/02/2021 | - |
Directeur des opérations | 25/11/2019 | - | |
Fondateur | 25/11/2019 | - |
Historique de carrière de Miao Liu
Formation de Miao Liu
Peking University | Undergraduate Degree |
Statistiques
Internationale
Chine | 3 |
Opérationnelle
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |